How many have died from undiagnosed human immunodeficiency virus-associated histoplasmosis, a treatable disease? Time to act

American Journal of Tropical Medicine and Hygiene

Volumn 90, Issue 2, 2014, Pages 193-194

  Nacher, Mathieu ^a   Adenis, Antoine ^a   Aznar, Christine ^a   Blanchet, Denis ^a   Vantilcke, Vincent ^b   Demar, Magalie ^a   Carme, Bernard ^a   Couppié, Pierre ^c  

^a CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

^b Centre Hospitalier de l'Ouest Guyanais   (French Guiana)

^c UNIVERSITÉ DES ANTILLES ET DE LA GUYANE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HISTOPLASMIN; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALGORITHM; HEALTH CARE COST; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED HISTOPLASMOSIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INDUSTRIALIZATION; MORTALITY; NONHUMAN; SHORT SURVEY; TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CENTRAL AMERICA; HISTOPLASMA; HISTOPLASMOSIS; HIV INFECTIONS; HUMANS; INCIDENCE; PREVALENCE; SOUTH AMERICA; TUBERCULOSIS; UNITED STATES;

EID: 84893506487     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.13-0226     Document Type: Short Survey

References (13)

1. Cohen J, 2006. HIV/AIDS: Latin America and the Caribbean, South America. Science 313: 484.
2. Nacher M, Vantilcke V, Parriault MC, Van Melle A, Hanf M, Labadie G, Romeo M, Adriouch L, Carles G, Couppie P, 2010. What is driving the HIV epidemic in French Guiana? Int J STD AIDS 21: 359-361.
3. Brazil MoHo, 2012. Boletim Epidemiológico Aids e DST, 2012 Report.
4. OAS States, 2005. Amazon River Basin.
5. Colombo AL, Tobon A, Restrepo A, Queiroz-Telles F, Nucci M, 2011. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol 49: 785-798.
6. Krug ES, Glenn HR, 1948. Comparative studies in tuberculosis and histoplasmosis among 2000 students entering Pennsylvania State College, September, 1947. J Lancet 68: 206-208.
7. Couppie P, Aznar C, Carme B, Nacher M, 2006. American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and prognosis. Curr Opin Infect Dis 19: 443-449. (Pubitemid 44338103)
8. Huber F, Nacher M, Aznar C, Pierre-Demar M, El Guedj M, Vaz T, Vantilcke V, Mahamat A, Magnien C, Chauvet E, Carme B, Couppie P, 2008. AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana. AIDS 22: 1047-1053. (Pubitemid 351769743)
9. Couppie P, Sobesky M, Aznar C, Bichat S, Clyti E, Bissuel F, El Guedj M, Alvarez F, Demar M, Louvel D, Pradinaud R, Carme B, 2004. Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors. Clin Infect Dis 38: 134-138. (Pubitemid 38045884)
10. Nacher M, Adenis A, Adriouch L, Dufour J, Papot E, Hanf M, Vantilcke V, Calvez M, Aznar C, Carme B, Couppie P, 2011. What is AIDS in the Amazon and the Guianas? Establishing the burden of disseminated histoplasmosis. Am J Trop Med Hyg 84: 239-240.
11. Hay RJ, White HS, Fields PE, Quamina DB, Dan M, Jones TR, 1981. Histoplasmosis in the eastern Caribbean: a preliminary survey of the incidence of the infection. J Trop Med Hyg 84: 9-12. (Pubitemid 12248192)
12. Ajello L, 1971. The medical mycological iceberg. HSMHA Health Rep 86: 437-448.
13. Initiative DND, 2012. Alternative Formulations of Amphotericin B.